Clinical Trial: A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Study Status: Completed
Recruit Status: RECRUITING
Condition: Atrial Fibrillation
Study Type: INTERVENTIONAL
Official Title: A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participan
Brief Summary:
The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non- central nervous system (CNS) systemic embolism.
Read more